These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 8082712)
1. Phosphoramidon does not inhibit endogenous endothelin-1 release stimulated by hemorrhage, cytokines and hypoxia in rats. Vemulapalli S; Chiu PJ; Griscti K; Brown A; Kurowski S; Sybertz EJ Eur J Pharmacol; 1994 May; 257(1-2):95-102. PubMed ID: 8082712 [TBL] [Abstract][Full Text] [Related]
2. Rhamnose moiety of phosphoramidon is not required for in vivo inhibition of endothelin converting enzyme. Pollock DM; Shiosaki K; Sullivan GM; Opgenorth TJ Biochem Biophys Res Commun; 1992 Jul; 186(2):1146-50. PubMed ID: 1497648 [TBL] [Abstract][Full Text] [Related]
3. Disparate effects of phosphoramidon on blood pressure in SHR and DOCA-salt hypertensive rats. Vemulapalli S; Watkins RW; Brown A; Cook J; Bernardino V; Chiu PJ Life Sci; 1993; 53(10):783-93. PubMed ID: 8355566 [TBL] [Abstract][Full Text] [Related]
4. Structure activity relationship of phosphoramidon derivatives for in vivo endothelin-converting-enzyme inhibition. Bigaud M; Hauss B; Schalk C; Jauch MF; D'Orchymont H Fundam Clin Pharmacol; 1994; 8(2):155-61. PubMed ID: 8020872 [TBL] [Abstract][Full Text] [Related]
5. Effect of phosphoramidon (endothelin converting enzyme inhibitor) and BQ-123 (endothelin receptor subtype A antagonist) on blood pressure in hypertensive rats. McMahon EG; Palomo MA; Brown MA; Bertenshaw SR; Carter JS Am J Hypertens; 1993 Aug; 6(8):667-73. PubMed ID: 8217029 [TBL] [Abstract][Full Text] [Related]
6. Attenuation of ischemic acute renal failure by phosphoramidon in rats. Vemulapalli S; Chiu PJ; Chintala M; Bernardino V Pharmacology; 1993 Sep; 47(3):188-93. PubMed ID: 8415869 [TBL] [Abstract][Full Text] [Related]
7. Role of endothelin-converting enzyme in the systemic hemodynamics and regional circulatory effects of proendothelin-1 (1-38) and diaspirin cross-linked hemoglobin in rats. Gulati A; Singh R; Chung SM; Sen AP J Lab Clin Med; 1995 Dec; 126(6):559-70. PubMed ID: 7490515 [TBL] [Abstract][Full Text] [Related]
8. Local formation and degradation of endothelin-1 in guinea pig airway tissues. Noguchi K; Fukuroda T; Ikeno Y; Hirose H; Tsukada Y; Nishikibe M; Ikemoto F; Matsuyama K; Yano M Biochem Biophys Res Commun; 1991 Sep; 179(2):830-5. PubMed ID: 1898406 [TBL] [Abstract][Full Text] [Related]
9. A role for endothelin in bicuculline-induced neurogenic pulmonary oedema in rats. Herbst C; Tippler B; Shams H; Simmet T Br J Pharmacol; 1995 Jul; 115(5):753-60. PubMed ID: 8548173 [TBL] [Abstract][Full Text] [Related]
11. Phosphoramidon, an endothelin converting enzyme inhibitor attenuates local gastric ischemia-reperfusion injury in rats. Hassan M; Kashimura H; Matsumaru K; Nakahara A; Fukutomi H; Muto H; Goto K; Tanaka N Life Sci; 1997; 61(10):PL 141-7. PubMed ID: 9296343 [TBL] [Abstract][Full Text] [Related]
12. Phosphoramidon, a metalloproteinase inhibitor, suppresses the hypertensive effect of big endothelin-1. Matsumura Y; Hisaki K; Takaoka M; Morimoto S Eur J Pharmacol; 1990 Aug; 185(1):103-6. PubMed ID: 2226629 [TBL] [Abstract][Full Text] [Related]
13. Conversion of big ET-1 in the rat lung: role of phosphoramidon-sensitive endothelin-1-converting enzyme. Hisaki K; Matsumura Y; Maekawa H; Fujita K; Takaoka M; Morimoto S Am J Physiol; 1994 Feb; 266(2 Pt 2):H422-8. PubMed ID: 8141343 [TBL] [Abstract][Full Text] [Related]
15. Phosphoramidon abolishes the increases in endothelin-1 release induced by ischemia-hypoxia in isolated perfused guinea pig lungs. Vemulapalli S; Rivelli M; Chiu PJ; del Prado M; Hey JA J Pharmacol Exp Ther; 1992 Sep; 262(3):1062-9. PubMed ID: 1527713 [TBL] [Abstract][Full Text] [Related]
16. Phosphoramidon, a metalloproteinase inhibitor, suppresses the secretion of endothelin-1 from cultured endothelial cells by inhibiting a big endothelin-1 converting enzyme. Ikegawa R; Matsumura Y; Tsukahara Y; Takaoka M; Morimoto S Biochem Biophys Res Commun; 1990 Sep; 171(2):669-75. PubMed ID: 2206130 [TBL] [Abstract][Full Text] [Related]
17. Effects of metalloprotease inhibitors on the conversion of proendothelin-1 to endothelin-1. Trapani AJ; Balwierczak JL; Lappe RW; Stanton JL; Graybill SC; Hopkins MF; Savage P; Sperbeck DM; Jeng AY Biochem Mol Biol Int; 1993 Dec; 31(5):861-7. PubMed ID: 8136704 [TBL] [Abstract][Full Text] [Related]
18. Effect of phosphoramidon on big endothelin-2 conversion into endothelin-2 in human renal adenocarcinoma (ACHN) cells. Analysis of endothelin-2 biosynthetic pathway. Yorimitsu K; Shinmi O; Nishiyama M; Moroi K; Sugita Y; Saito T; Inagaki Y; Masaki T; Kimura S FEBS Lett; 1992 Dec; 314(3):395-8. PubMed ID: 1468574 [TBL] [Abstract][Full Text] [Related]
19. Measurement of C-terminal fragment of big endothelin-1: a novel method for assessing the generation of endothelin-1 in humans. Plumpton C; Haynes WG; Webb DJ; Davenport AP J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S34-6. PubMed ID: 8587408 [TBL] [Abstract][Full Text] [Related]